Jim Gaffigan reveals his weight loss journey with Mounjaro tackling food addiction and societal stigma while balancing comedy ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans’ desire to slim down. While ...

A spokesperson for Eli Lilly told CBS News that "all doses of Mounjaro and Zepbound" are available ... of practical 'speedbumps.'" Patients face hurdles like getting a new prescription and ...

A group representing these pharmacies sued the FDA because, on October 2, the agency said there was no longer a shortage of the drugs called tirzepatide, which are sold as Mounjaro for diabetes ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Eli Lilly has received approval to start selling its weight loss drug, Mounjaro, in Hong Kong as early as the end ...

Eli Lilly will report third-quarter earnings Wednesday morning. Investor focus remains on the production and sales of its ...

Mounjaro & Zepbound: Key Top-Line Drivers for Lilly Tirzepatide ... Lilly’s tirzepatide medicines face strong competition ...

Mounjaro recorded sales of $3.11 billion during ... Lilly’s tirzepatide medicines face strong competition from Novo Nordisk’s NVO semaglutide. Semaglutide is approved as Ozempic pre-filled ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...